BDBM38838 5-benzyl-6,11-diketo-benzo[b][1,4]benzothiazepine-3-carboxylic acid::5-benzyl-6,11-dioxobenzo[b][1,4]benzothiazepine-3-carboxylic acid::6,11-bis(oxidanylidene)-5-(phenylmethyl)benzo[b][1,4]benzothiazepine-3-carboxylic acid::6,11-dioxo-5-(phenylmethyl)-3-benzo[b][1,4]benzothiazepinecarboxylic acid::MLS000120756::SMR000097598::cid_5307330

SMILES OC(=O)c1ccc2c(c1)N(Cc1ccccc1)C(=O)c1ccccc1S2=O

InChI Key InChIKey=HWNAOVQMXCUIDE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 38838   

TargetM-phase inducer phosphatase 2(Human)
University of Pittsburgh

Curated by PubChem BioAssay
LigandPNGBDBM38838(5-benzyl-6,11-dioxobenzo[b][1,4]benzothiazepine-3-...)
Affinity DataIC50: 5.00E+4nMAssay Description:The Cdc25B Phosphatase HTS dose response confirmation has been developed to confirm actives identified in the Cdc25B HTS AID 368, screened at the Uni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2011
Entry Details
PCBioAssay